Aileen Healy is a high-level expert, working in Pfizer main office of which is in 4. on the position of Executive Director and Global Head, Es and I For Rare Diseases since 2017. This person gained professional experience in more than seven positions at different companies. Aileen Healy went to the Griffith College Cork and received education there. Boston, Massachusetts is the area, where this professional was lastly known to be located. The professional's email address and phone number are easily accessed through SoftwareOfficial on demand.
Name variants:
Eileen Healy,
Alene Healy,
Allie Healy,
Lena Healy
Last updated May 31, 2024
Contact Information
Last Update
Jun 25, 2022
Email
ah**@momentapharma.com, he**@gmail.com, ah**@cydanco.com
Location
Boston, MA
Company
Workplace
Executive Director and Global Head, Es and I For Rare Diseases
New York, NY
Industry
Pharmaceuticals
Colleagues
Work History
Vice President, Preclinical Development at Cydan Development Co
700 Technology Sq, Cambridge, MA 02139
Cydan Development is an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential. Cydan focuses on selecting promising assets with well-underst...
2013 — 2017
Vice President, Research
840 Memorial Dr, Cambridge, MA 02139
Strategic scientific leadership of all preclinical research activities for a start-up pharmaceutical company focused on bringing small molecule therapies for rare, neurodevelopmental disorde...
2008 — 2013
Associate Director of Biology
301 Binney St, Cambridge, MA 02142
Managed biology discovery team developing a fully substitutable generic version of Copaxone® (Glatopa™ - glatiramer acetate injection). Executed research plan for bioassay development. Ident...
2006 — 2008
Assistant Research Professor of Medicine, the Pulmonary Center
1996 — 2001
Occupations
Executive
Chief Executive Officer
Vice President
Corporate Executive
Chief Executive
Skills
Life Sciences
Pharmaceutical Industry
Biotechnology
Biopharmaceuticals
Drug Discovery
Drug Development
Clinical Development
Cardiovascular Disease
Inflammation
Immunology
Oncology
Rare Diseases
Molecular and Cellular Biology
Biochemistry
Assay Development
Biomarker Discovery